Kathy Oubre Explains How Biosimilar Savings Help Dispel Clinician Worries

Kathy Oubre, MS, chief operating officer of Pontchartrain Cancer Center, explains how biosimilars helping to rid worries about the affordability of biologic drugs helps clinicians.

Transcript:

How much of a relief to clinicians is it to have biosimilars for expensive reference products available?

Oubre: So, when talking about biosimilars within our organization, we often use the phrase "quality without compromise." And biosimilars have really helped kind of check that box because it allows us and our providers to provide the same high quality care to our patients, while decreasing some of that financial impact to them.